Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Clinical trial NCT07353931 · RECRUITING

Trial details

NCT number: NCT07353931
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis Overweight or Obesity

Start date: 2026-02-09
Primary completion: 2028-03-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.